Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of HIV Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of HIV Drugsmarket, defines the market attractiveness level of HIV Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of HIV Drugs industry, describes the types of HIV Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global HIV Drugs market and the development prospects and opportunities of HIV Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HIV Drugs market in Chapter 13.
By Player:
Johnson & Johnson
Merck
GlaxoSmithKline
Bristol-Myers Squibb
Gilead Sciences
By Type:
Multi-class Combination Products
Nucleoside Reverse Transcriptase Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Entry Inhibitors - CCR5 Co-Receptor Antagonist
HIV Integrase Strand Transfer Inhibitors
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 HIV Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 HIV Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 HIV Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 HIV Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise HIV Drugs Market Analysis and Outlook to 2022
-
7.1 Global HIV Drugs Consumption (2017-2022)
-
7.2 United States HIV Drugs Consumption (2017-2022)
-
7.3 Europe HIV Drugs Consumption (2017-2022)
-
7.4 China HIV Drugs Consumption (2017-2022)
-
7.5 Japan HIV Drugs Consumption (2017-2022)
-
7.6 India HIV Drugs Consumption (2017-2022)
-
7.7 South Korea HIV Drugs Consumption (2017-2022)
8 Region and Country-wise HIV Drugs Market Analysis and Outlook to 2028
-
8.1 Global HIV Drugs Consumption Forecast (2022-2028)
-
8.2 United States HIV Drugs Consumption Forecast (2022-2028)
-
8.3 Europe HIV Drugs Consumption Forecast (2022-2028)
-
8.4 China HIV Drugs Consumption Forecast (2022-2028)
-
8.5 Japan HIV Drugs Consumption Forecast (2022-2028)
-
8.6 India HIV Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea HIV Drugs Consumption Forecast (2022-2028)
9 Global HIV Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global HIV Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Multi-class Combination Products Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Non-Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Fusion Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Entry Inhibitors - CCR5 Co-Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
9.1.7 Global HIV Integrase Strand Transfer Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global HIV Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global HIV Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global HIV Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Multi-class Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Non-Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Fusion Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Entry Inhibitors - CCR5 Co-Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global HIV Integrase Strand Transfer Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global HIV Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global HIV Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global HIV Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global HIV Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 HIV Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global HIV Drugs Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson HIV Drugs Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck HIV Drugs Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline HIV Drugs Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb HIV Drugs Product and Service
-
14.5 Gilead Sciences
-
14.5.1 Gilead Sciences Company Details
-
14.5.2 Gilead Sciences HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gilead Sciences HIV Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of HIV Drugs
-
Figure HIV Drugs Picture
-
Table Global HIV Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HIV Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HIV Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global HIV Drugs Consumption by Country (2017-2022)
-
Figure United States HIV Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe HIV Drugs Consumption and Growth Rate (2017-2022)
-
Figure China HIV Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan HIV Drugs Consumption and Growth Rate (2017-2022)
-
Figure India HIV Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea HIV Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States HIV Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe HIV Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China HIV Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan HIV Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India HIV Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea HIV Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multi-class Combination Products Consumption and Growth Rate (2017-2022)
-
Figure Global Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Fusion Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Entry Inhibitors - CCR5 Co-Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Integrase Strand Transfer Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Multi-class Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fusion Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Entry Inhibitors - CCR5 Co-Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV Integrase Strand Transfer Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global HIV Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global HIV Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson HIV Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck HIV Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline HIV Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb HIV Drugs Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences HIV Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences HIV Drugs Product and Service
-
